 |
For all your Quality Management and Continual Improvement Initiatives and Standards
|
| View previous topic :: View next topic |
| Author |
Message |
GaryW Site Admin

Joined: 14 Oct 2005 Posts: 106530 Location: Adelaide, Australia

|
Posted: Wed Sep 08, 2010 6:48 am Post subject: ThromboGenics Presents Positive Pooled Results From The MIVI-TRUST Phase III Program |
|
|
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France...
Read more...
Source: Pharma Industry / Biotech Industry News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day. _________________ Regards,
Gary Wilkinson
Founder & Principal Consultant
SQR Consulting |
|
| Back to top |
|
 |
|
|
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum You cannot attach files in this forum You cannot download files in this forum
|
|
|
© 2005 SQR Consulting - All rights reserved
ABN : 60512166070
Powered by phpBB © 2001, 2005 phpBB Group
|